These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33012876)

  • 1. An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis.
    Nuñez NA; Joseph B; Pahwa M; Seshadri A; Prokop LJ; Kung S; Schak KM; Vande Voort JL; Frye MA; Singh B
    Psychopharmacol Bull; 2020 Sep; 50(4):137-163. PubMed ID: 33012876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Ketamine for Depression: A Systematic Review.
    Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials.
    Kryst J; Kawalec P; Mitoraj AM; Pilc A; Lasoń W; Brzostek T
    Pharmacol Rep; 2020 Jun; 72(3):543-562. PubMed ID: 32301056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis.
    Bahji A; Zarate CA; Vazquez GH
    Expert Opin Drug Saf; 2022 Jun; 21(6):853-866. PubMed ID: 35231204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
    Maneeton N; Maneeton B; Srisurapanont M; Martin SD
    BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
    Bahji A; Vazquez GH; Zarate CA
    J Affect Disord; 2021 Jan; 278():542-555. PubMed ID: 33022440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review.
    Memon RI; Naveed S; Faquih AE; Fida A; Abbas N; Chaudhary AMD; Qayyum Z
    Psychiatr Q; 2020 Dec; 91(4):1147-1192. PubMed ID: 32852658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intravenous ketamine on depressive symptoms after surgery: A systematic review.
    Wang J; Sun Y; Ai P; Cui V; Shi H; An D; Wu A; Wei C
    J Clin Anesth; 2022 May; 77():110631. PubMed ID: 34971992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ketamine for depression: An updated systematic review.
    Meshkat S; Haikazian S; Di Vincenzo JD; Fancy F; Johnson D; Chen-Li D; McIntyre RS; Mansur R; Rosenblat JD
    World J Biol Psychiatry; 2023; 24(7):545-557. PubMed ID: 36651238
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.
    McIntyre RS; Carvalho IP; Lui LMW; Majeed A; Masand PS; Gill H; Rodrigues NB; Lipsitz O; Coles AC; Lee Y; Tamura JK; Iacobucci M; Phan L; Nasri F; Singhal N; Wong ER; Subramaniapillai M; Mansur R; Ho R; Lam RW; Rosenblat JD
    J Affect Disord; 2020 Nov; 276():576-584. PubMed ID: 32871689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
    Menon V; Varadharajan N; Faheem A; Andrade C
    JAMA Psychiatry; 2023 Jun; 80(6):639-642. PubMed ID: 37043224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis.
    Nunez NA; Joseph B; Kumar R; Douka I; Miola A; Prokop LJ; Mickey BJ; Singh B
    Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.
    Xu Y; Hackett M; Carter G; Loo C; Gálvez V; Glozier N; Glue P; Lapidus K; McGirr A; Somogyi AA; Mitchell PB; Rodgers A
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26578082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):149-161. PubMed ID: 27318835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
    McGirr A; Berlim MT; Bond DJ; Fleck MP; Yatham LN; Lam RW
    Psychol Med; 2015 Mar; 45(4):693-704. PubMed ID: 25010396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
    Faridhosseini F; Sadeghi R; Farid L; Pourgholami M
    Hum Psychopharmacol; 2014 May; 29(3):216-23. PubMed ID: 24911574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.